Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells

J A McCubrey1, J T Lee, L S Steelman

  • 1Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA.

Insights

The Raf/MEK/ERK pathway, when activated, can promote oncogenic transformation in hematopoietic cells, especially when combined with anti-apoptotic proteins. This pathway

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The PI3K/Akt and Raf/MEK/ERK signaling pathways are crucial for cell growth, survival, and gene expression.
  • These pathways transmit signals from cell surface receptors to intracellular targets.
  • Dysregulation of these pathways is implicated in various cancers.

Purpose of the Study:

  • To investigate the roles of PI3K/Akt and Raf/MEK/ERK signaling in abrogating cytokine dependence in hematopoietic cells.
  • To determine the oncogenic potential of activated Raf/MEK/ERK signaling.
  • To explore the interactions between these pathways and anti-apoptotic proteins in cell transformation.

Main Methods:

  • Retroviral expression of activated PI3K, Akt, Raf, and MEK proteins in hematopoietic cell lines (FDC-PI, TF-1, FL5.12).
  • Assessment of cytokine independence and transformation frequency.
  • Tumorigenicity assays in immunocompromised mice.
  • Co-expression studies with anti-apoptotic proteins (Bcl-2, Bcl-XL).

Main Results:

  • Activated PI3K or Akt alone did not efficiently abolish cytokine dependence.
  • Activated Raf and MEK abrogated cytokine dependence in FDC-PI and TF-1 cells, with transformation efficiency varying by specific oncogene.
  • Cytokine-independent cells driven by activated Raf formed tumors in mice, confirming oncogenic effects.
  • Overexpression of Bcl-2 enhanced Raf/MEK/ERK-mediated transformation.
  • Activated Raf genes did not relieve cytokine dependence in FL5.12 cells, but combinations with PI3K or Akt did, further enhanced by Bcl-2/Bcl-XL.

Conclusions:

  • The Raf/MEK/ERK pathway activation can lead to oncogenic transformation of certain hematopoietic cells.
  • Interactions between the Raf/MEK/ERK pathway and PI3K/Akt pathway, along with anti-apoptotic proteins, can overcome cytokine dependence and promote transformation.
  • These findings highlight the complex interplay of signaling pathways in cancer development and suggest potential therapeutic targets.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...